← Back to headlines
HSE Agrees to Fund Friedreich's Ataxia Drug in Ireland
The Health Service Executive (HSE) in Ireland has agreed to fund a drug for patients suffering from Friedreich's ataxia. This decision is expected to provide clarity and access to treatment for those affected by the rare genetic disorder.
25 Aug, 06:30 — 25 Aug, 11:06
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (37/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left2
Left (2)
irish-timesthe-journal
Center
Right1
Right (1)
irish-independent
Far R
Geographic diversity— 1 region4/34
Ireland3
ℹAll sources from Ireland region
Sources
Showing 3 of 3 sources
irish-timesHigh1h ago
HSE agrees to fund drug for patients with Friedreich’s ataxia
Omaveloxolone, branded as Skyclarys, has been approved in US and Europe for treatment of disease
By Shauna Bowers
Read full article →irish-independent5h ago
HSE senior management team to make final decision on Friedrich Ataxia drug funding
People suffering from rare disease ‘beg’ for life-changing medicine
By Cate McCurry
Read full article →the-journal2h ago
Tánaiste hopes today's HSE decision on Friedreich's ataxia drug gives patients 'clarity'
The issue has become a political one in recent weeks, with opposition politicians calling for the HSE to approve the funding of the drug.
Read full article →Coverage Timeline
First report: irish-independent · 25 Aug, 06:30|Full coverage: 3 · 5h|Window: 5h
Left-leaningCenterRight-leaning
Related Stories
New Study Finds High Prevalence of CTE in Former NFL Players
14m ago
Europe Records Over 35,000 Excess Deaths From Successive Heatwaves
18m ago
No West Nile Virus Cases Reported in FBiH, Public Health Director Urges Preparedness
1h ago
Critical Heat Measurements in Vienna Senior Apartments Prompt Calls for Subsidized Air Conditioning
1h ago